CYP2D6 polymorphism in systemic lupus erythematosus patients


Kortunay S., Bozkurt A., Bathum L., Basci N. E. , Calguneri M., Brosen K., ...Daha Fazla

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, cilt.55, ss.21-25, 1999 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 55 Konu: 1
  • Basım Tarihi: 1999
  • Doi Numarası: 10.1007/s002280050587
  • Dergi Adı: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • Sayfa Sayıları: ss.21-25

Özet

Objectives: To determine whether patients with idiopathic systemic lupus erythematosus (SLE) are associated with impaired CYP2D6 activity and to gain insight into whether there is an association between particular CYP2D6 genotypes and susceptibility to SLE, and whether CYP2D6 polymorphism is linked to any specific clinical features of SLE.